Beta Bionics, Inc.
BBNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $867,008 | $631,768 | $375,949 | $1,024,333 |
| - Cash | $38,485 | $35,075 | $42,454 | $30,432 |
| + Debt | $7,687 | $6,687 | $6,974 | $7,255 |
| Enterprise Value | $836,210 | $603,380 | $340,469 | $1,001,156 |
| Revenue | $27,253 | $23,238 | $17,639 | $20,440 |
| % Growth | 17.3% | 31.7% | -13.7% | – |
| Gross Profit | $15,119 | $12,503 | $8,971 | $11,689 |
| % Margin | 55.5% | 53.8% | 50.9% | 57.2% |
| EBITDA | -$13,526 | -$16,216 | -$18,038 | -$17,579 |
| % Margin | -49.6% | -69.8% | -102.3% | -86% |
| Net Income | -$14,209 | -$16,869 | -$28,656 | -$18,108 |
| % Margin | -52.1% | -72.6% | -162.5% | -88.6% |
| EPS Diluted | -0.33 | -0.39 | -0.93 | -0.42 |
| % Growth | 15.4% | 58.1% | -121.4% | – |
| Operating Cash Flow | -$8,729 | -$13,594 | -$19,975 | -$14,279 |
| Capital Expenditures | -$1,282 | -$1,779 | -$333 | -$561 |
| Free Cash Flow | -$10,011 | -$15,373 | -$20,308 | -$14,840 |